Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.

Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF, Yeh JI, Hsu HY.

Cancer Lett. 2012 Jun 28;319(2):203-13. doi: 10.1016/j.canlet.2012.01.006.

PMID:
22306340
2.

Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.

Lin Y, Yang X, Lu M, Zheng W, Zhang J, Zhuang H, Hua ZC.

Anticancer Drugs. 2013 Oct;24(9):945-57. doi: 10.1097/CAD.0b013e3283651862.

PMID:
23958791
3.
4.

Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.

Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.

Oncogene. 2001 Nov 29;20(55):8009-18.

5.

Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.

Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S.

Anticancer Res. 2006 Jan-Feb;26(1A):259-65.

6.

Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.

Lin Y, Peng N, Li J, Zhuang H, Hua ZC.

Mol Cancer. 2013 Jun 8;12:54. doi: 10.1186/1476-4598-12-54.

7.

Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.

Ho JN, Byun SS, Lee S, Oh JJ, Hong SK, Lee SE, Yeon JS.

J Urol. 2015 Mar;193(3):1016-22. doi: 10.1016/j.juro.2014.09.007.

PMID:
25229559
8.

Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells.

Yao J, Jiang Z, Duan W, Huang J, Zhang L, Hu L, He L, Li F, Xiao Y, Shu B, Liu C.

Biol Pharm Bull. 2008 Apr;31(4):592-7.

9.

Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.

Zhu W, Li J, Wu S, Li S, Le L, Su X, Qiu P, Hu H, Yan G.

Pancreas. 2012 Oct;41(7):1029-38. doi: 10.1097/MPA.0b013e31824abdc0.

PMID:
22617708
10.

Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.

Wu PP, Liu KC, Huang WW, Ma CY, Lin H, Yang JS, Chung JG.

Oncol Rep. 2011 Feb;25(2):551-7. doi: 10.3892/or.2010.1080.

PMID:
21152873
11.

Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells.

Shu B, Duan W, Yao J, Huang J, Jiang Z, Zhang L.

Toxicol In Vitro. 2009 Jun;23(4):598-602. doi: 10.1016/j.tiv.2009.01.021.

PMID:
19233258
13.

Triptolide circumvents drug-resistant effect and enhances 5-fluorouracil antitumor effect on KB cells.

Chen YW, Lin GJ, Chuang YP, Chia WT, Hueng DY, Lin CK, Nieh S, Sytwu HK.

Anticancer Drugs. 2010 Jun;21(5):502-13. doi: 10.1097/CAD.0b013e328337337c.

PMID:
20154595
14.

Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.

Alsaied OA, Sangwan V, Banerjee S, Krosch TC, Chugh R, Saluja A, Vickers SM, Jensen EH.

Surgery. 2014 Aug;156(2):270-9. doi: 10.1016/j.surg.2014.04.055.

PMID:
24953273
15.

Enhanced antitumor effect of combined triptolide and ionizing radiation.

Wang W, Yang S, Su Y, Xiao Z, Wang C, Li X, Lin L, Fenton BM, Paoni SF, Ding I, Keng P, Okunieff P, Zhang L.

Clin Cancer Res. 2007 Aug 15;13(16):4891-9.

16.

Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway.

Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J, Kim YH.

Int J Oncol. 2010 Nov;37(5):1177-85.

PMID:
20878065
17.

Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.

Jiang QW, Cheng KJ, Mei XL, Qiu JG, Zhang WJ, Xue YQ, Qin WM, Yang Y, Zheng DW, Chen Y, Wei MN, Zhang X, Lv M, Chen MW, Wei X, Shi Z.

Oncotarget. 2015 Oct 20;6(32):32790-804. doi: 10.18632/oncotarget.5411.

19.

Triptolide induces apoptotic death of T lymphocyte.

Yang Y, Liu Z, Tolosa E, Yang J, Li L.

Immunopharmacology. 1998 Aug;40(2):139-49.

PMID:
9826028
20.

Supplemental Content

Support Center